Administrative Core
行政核心
基本信息
- 批准号:10334982
- 负责人:
- 金额:$ 64.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-15 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesApplications GrantsAtmosphereAwardBiomedical EngineeringBudgetsCancer CenterCenters of Research ExcellenceClinicalClinical DataClinical ResearchCollaborationsCommittee MembersCritiquesDiagnosisEarly DiagnosisEducational workshopEngineeringEnsureEnvironmentEvaluationFacultyFeedbackFinancial ActivityFosteringFundingFunding AgencyFunding MechanismsGoalsGrantImage EnhancementIndividualInfrastructureK-Series Research Career ProgramsLeadershipLearningLogisticsMalignant NeoplasmsMapsMedical ImagingMedical centerMentorsMissionModelingMonitorOklahomaOperations ResearchPerformancePhasePhysiciansPilot ProjectsPoliciesProcessRegulationRequest for ApplicationsResearchResearch ActivityResearch InfrastructureResearch PersonnelResearch Project GrantsResearch SupportResourcesRoleScheduleScientistScreening for cancerSecureServicesStudy SectionSurveysTrainingTravelUnited States National Institutes of HealthUniversitiesWorkbasebiomedical imagingcareercareer developmentclinical imagingcollegedata resourcedesignimprovedmeetingsoperationrecruitsuccesssymposiumsynergismtechnology developmenttranslational cancer research
项目摘要
ABSTRACT – Administrative Core
The overarching objective of this COBRE is to promote medical imaging related translational cancer research
with a common research theme aiming to improve efficacy of cancer screening, early detection, diagnosis, and
treatment through the collaborative efforts between the biomedical engineering researchers and the physician
scientists in the University of Oklahoma. In order to support the objective of this COBRE application, the
Administrative Core will provide leadership and guidance to ensure the efficient operation and management of
all components of the COBRE through effective oversight, fiscal responsibility, and a transparent administrative
infrastructure. PD/PI of this COBRE will work closely with the external advisory committee (EAC) and internal
advisory committee (IAC) to guide and monitor the progress of the overall operation of the Administrative Core,
all research projects and two research resource supporting cores of this COBRE. Specifically, the Administrative
Core has multiple essential operation activities including to (1) coordinate the research and mentoring activities,
(2) communicate with the oversight committees (i.e. the EAC, IAC and other advisory committees of two research
resource supporting cores), (3) assess progress of both the COBRE as a whole and the individual cores, (4)
evaluate progress and milestones of the junior research project leaders (RPLs) in their research projects and
career development, (5) select and manage the pilot projects to build a sustainable pipeline of the RPLs, (6)
identify and recruit new RPLs to replace the RPLs who graduate from the COBRE, (7) organize research
seminars and workshops, (8) manage budget of the COBRE and track all financial activities, and (9) monitor all
COBRE activities to ensure the compliance with all federal research policies and regulations. The Administrative
Core will also include a COBRE Coordinator to assist Core Director in the management of routine fiscal and
grant activities of the COBRE, such as helping with scheduling meetings and conference rooms as needed,
video and tele-conferencing needs as necessary, securing venues for seminars and workshops, and scheduling
travel plans and generating itineraries for the EAC members and the invited speakers. Thus, in order to
successfully fulfill the goals or tasks of this Administrative Core, we propose the following three Specific Aims.
Aim 1: we will support a well-integrated administrative infrastructure to effectively coordinate mentoring and
oversight of the promising RPLs and the pilot project investigators in conducting their research projects and
career development. Aim 2: we will establish and implement the selection and evaluation criteria for sustaining
the pool of promising junior investigators for RPLs in this COBRE. Aim 3: we will support the research resource
supporting cores to help promote and enhance the medical imaging related translational cancer research
activities and synergy between the resource supporting cores and research projects.
摘要-行政核心
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bin Zheng其他文献
Bin Zheng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bin Zheng', 18)}}的其他基金
Oklahoma Center of Medical Imaging for Translational Cancer Research
俄克拉荷马州转化癌症研究医学影像中心
- 批准号:
10334981 - 财政年份:2022
- 资助金额:
$ 64.25万 - 项目类别:
Regulation of interferon signaling in melanoma by the cohesin complex protein STAG2 via 3D genome organization
粘连蛋白复合物 STAG2 通过 3D 基因组组织调节黑色素瘤中的干扰素信号传导
- 批准号:
10905899 - 财政年份:2022
- 资助金额:
$ 64.25万 - 项目类别:
Targeting the LKB1-AMPK pathway in melanoma: Mechanism and preclinical evaluation
靶向黑色素瘤中的 LKB1-AMPK 通路:机制和临床前评估
- 批准号:
9690391 - 财政年份:2012
- 资助金额:
$ 64.25万 - 项目类别:
Mammographic Density and Tissue Asymmetry Based Breast Cancer Risk Stratification
基于乳房 X 光密度和组织不对称性的乳腺癌风险分层
- 批准号:
8691598 - 财政年份:2012
- 资助金额:
$ 64.25万 - 项目类别:
Targeting the LKB1-AMPK pathway in melanoma: Mechanism and preclinical evaluation
靶向黑色素瘤中的 LKB1-AMPK 通路:机制和临床前评估
- 批准号:
8723596 - 财政年份:2012
- 资助金额:
$ 64.25万 - 项目类别:
Targeting the LKB1-AMPK PATHWAY in Melanoma: Mechanism and Preclinical Evaluation
靶向黑色素瘤中的 LKB1-AMPK 通路:机制和临床前评估
- 批准号:
8466942 - 财政年份:2012
- 资助金额:
$ 64.25万 - 项目类别:
Mammographic Density and Tissue Asymmetry Based Breast Cancer Risk Stratification
基于乳房 X 光密度和组织不对称性的乳腺癌风险分层
- 批准号:
8826571 - 财政年份:2012
- 资助金额:
$ 64.25万 - 项目类别:
Targeting the LKB1-AMPK pathway in melanoma: Mechanism and preclinical evaluation
靶向黑色素瘤中的 LKB1-AMPK 通路:机制和临床前评估
- 批准号:
8657935 - 财政年份:2012
- 资助金额:
$ 64.25万 - 项目类别:
Mammographic Density and Tissue Asymmetry Based Breast Cancer Risk Stratification
基于乳房 X 光密度和组织不对称性的乳腺癌风险分层
- 批准号:
8282037 - 财政年份:2012
- 资助金额:
$ 64.25万 - 项目类别:
Targeting the LKB1-AMPK PATHWAY in Melanoma: Mechanism and Preclinical Evaluation
靶向黑色素瘤中的 LKB1-AMPK 通路:机制和临床前评估
- 批准号:
8275994 - 财政年份:2012
- 资助金额:
$ 64.25万 - 项目类别: